| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2921348 | Heart, Lung and Circulation | 2007 | 5 Pages |
Abstract
Our study suggests drug-eluting stents are safe, effective and the preferred therapy for in-stent restenosis. The incidence of recurrent drug-eluting stent restenosis at 12 months is low.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew E. FRACP, MD, FJFICM, Bryan P. FRACP, David J. FRACP, David MMed Sci, FRACP, Anthony FRACP, Robert FRACP, PhD, Adam Meehan, Angela RN, Chris PhD, Stephen J. FRACP, PhD,